COVID-19 Infusion Treatment
The Hospitals of Providence is providing the monoclonal antibody infusion treatment in an effort to prevent hospitalizations due to the progress of severe symptoms in high risk patients.
The monoclonal antibody infusion treatment is used in patients who meet the following criteria:
- COVID-19 positive
- Non-hospitalized adults and adolescents 12 years of age and older
- Mild to moderate symptoms
- Within 10 days of symptom onset
- No current need for supplemental oxygen
Patients who qualify for the treatment receive a one-time intravenous (or IV) dose that takes about 1 hour to infuse. Patients will be required to wait an additional hour to monitor the reaction to the treatment.
Patients who have received a positive test result for COVID-19 should talk with their doctor or healthcare provider to determine if the monoclonal antibody infusion treatment is right for them.
Infusion Therapy Letter - English
Infusion Therapy Letter - Spanish
For more infomation or to register for treatment visit The Hospitals of Providence website.
Learn More